FDA Adverse Event Injury Summary report: N

SELOX SR 45

MDR report key: 19416359 · Received May 28, 2024

Report

Report Number
MW5155476
Event Type
Injury
Date Received
May 28, 2024
Date of Event
February 27, 2024
Report Date
April 1, 2024
Manufacturer
BKC (BIOTRONIK, INC.) / BIOTRONIK SE & CO. KG
Product Code
NVN
Adverse Event
Yes
Report Source
Voluntary report
Reporter Location
MN, US
Reporter Occupation
UNKNOWN
Health Professional
*

Narratives

Description of Event or Problem · 0

THREE HUNDRED FORTY-FIVE MONITORED AT/AF EPISODES, MOST RECENT ONGOING SINCE (B)(6) 2024. INTERMITTENT ATRIAL UNDER-SENSING OBSERVED ON THESE EPISODES, LEADING TO EARLY TERMINATION OF EPISODE COLLECTION. DDIR MODE. NOT AFFECTING DEVICE FUNCTION. THIS REPORT REFLECTS INFORMATION RECEIVED BY FDA IN THE FORM OF A NOTIFICATION PER 803.22 (B)(2).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
331872 SELOX SR 45 DRUG ELUTING PERMANENT RIGHT VENTRICULAR (RV) OR RIGHT ATRIAL (RA) PACEMAKER ELE NVN BKC (BIOTRONIK, INC.) / BIOTRONIK SE & CO. KG 343081

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown